| 1 |
Forgie KA，Fialka N，Freed DH，et al．Lung Transplantation, Pulmonary Endothelial Inflammation, and Ex-Situ Lung Perfusion: A Review[J]．Cells，2021，10（6）：1417．
|
| 2 |
毛文君，陈静瑜．中国肺移植面临的困难及对策[J]．中华胸部外科电子杂志，2016，3（1）：1-6．
|
| 3 |
Bardossy AC，Snavely EA，Nazarian E，et al．Donor-derived transmission through lung transplantation of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 carbapenemase during an ongoing healthcare facility outbreak[J]．Transpl Infect Dis，2020，22（2）：e13256．
|
| 4 |
Bunsow E，Los-Arcos I，Martin-Gómez MT，et al．Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance[J]．J Infect，2020，80（2）：190-196．
|
| 5 |
Lee KH，Jeong SJ，Kim SY，et al．Effects of Multidrug-resistant Bacteria in Donor Lower Respiratory Tract on Early Posttransplant Pneumonia in Lung Transplant Recipients Without Pretransplant Infection[J]．Transplantation，2020，104（4）：e98-e106．
|
| 6 |
Kulkarni HS，Tsui K，Sunder S，et al．Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation[J]．Am J Transplant，2020，20（4）：1028-1038．
|
| 7 |
Mojtabaee M，Shahryari S，Sadegh Beigee F．Reasons for Donor Lungs Unsuitability After Radiographic Selection[J]．Exp Clin Transplant，2019，17（Suppl 1）：120-122．
|
| 8 |
Shepherd HM，Gauthier JM，Puri V，et al．Advanced considerations in organ donors[J]．J Thorac Dis，2021，13（11）：6528-6535．
|
| 9 |
Miñambres E，Rodrigo E，Ballesteros MA，et al．Impact of restrictive fluid balance focused to increase lung procurement on renal function after kidney transplantation[J]．Nephrol Dial Transplant，2010，25（7）：2352-2356．
|
| 10 |
Munshi L，Keshavjee S，Cypel M．Donor management and lung preservation for lung transplantation[J]．Lancet Respir Med，2013，1（4）：318-328．
|
| 11 |
Determann RM，Royakkers A，Wolthuis EK，et al．Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial[J]．Crit Care，2010，14（1）：R1．
|
| 12 |
Mascia L，Pasero D，Slutsky AS，et al．Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial[J]．JAMA，2010，304（23）：2620-2627．
|
| 13 |
Powner DJ，Graham R．Airway pressure release ventilation during adult donor care[J]．Prog Transplant，2010，20（3）：269-273．
|
| 14 |
Mehaffey JH，Charles EJ，Sharma AK，et al．Airway pressure release ventilation during ex vivo lung perfusion attenuates injury[J]．J Thorac Cardiovasc Surg，2017，153（1）：197-204．
|
| 15 |
Biswas Roy S，Razia D，Arjuna A，et al. Airway pressure release ventilation for in-vivo donor lung management and lung transplant outcomes[J/CD]．Chin J Thorac Surg（Electronic Edition），2022，9（2）．
|
| 16 |
Sadegh Beigee F，Daryani EN，Shahryari S，et al．Role of Methylprednisolone in the Management of Hemodynamically Unstable Brain-Dead Cases[J]．Exp Clin Transplant，2019，17（Suppl 1）：257-259．
|
| 17 |
Shemie SD，Ross H，Pagliarello J，et al．Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential[J]．CMAJ，2006，174（6）：S13-S32．
|
| 18 |
Van Zanden JE，'t Hart NA，Ottens PJ，et al．Methylprednisolone Treatment in Brain Death-Induced Lung Inflammation-A Dose Comparative Study in Rats[J]．Front Pharmacol，2021，12：587003．
|
| 19 |
Peled Y，Ram E，Klempfner R，et al．Donor thyroid hormone therapy and heart transplantation outcomes: ISHLT transplant registry analysis[J]．J Heart Lung Transplant，2020，39（10）：1070-1078．
|
| 20 |
Peled Y，Lavee J，Kassif Y，et al．Donor thyroid hormone therapy is associated with an increased risk of graft dysfunction after heart transplantation[J]．Clin Transplant，2020，34（7）：e13887．
|
| 21 |
Nagy á，Szécsi B，Eke C，et al．Endocrine Management and Hormone Replacement Therapy in Cardiac Donor Management: A Retrospective Observational Study[J]．Transplant Proc，2021，53（10）：2807-2815．
|
| 22 |
Chen-Yoshikawa TF．Ischemia-Reperfusion Injury in Lung Transplantation[J]．Cells，2021，10（6）：1333．
|
| 23 |
Christie JD，Sager JS，Kimmel SE，et al．Impact of primary graft failure on outcomes following lung transplantation[J]．Chest，2005，127（1）：161-165．
|
| 24 |
Kelly RF，Murar J，Hong Z，et al．Low potassium dextran lung preservation solution reduces reactive oxygen species production[J]．Ann Thorac Surg，2003，75（6）：150-155．
|
| 25 |
Van Raemdonck D．Thoracic organs: current preservation technology and future prospects; part 1: lung[J]．Curr Opin Organ Transplant，2010，15（2）：150-155．
|
| 26 |
Laubach VE，Sharma AK．Mechanisms of lung ischemia-reperfusion injury[J]．Curr Opin Organ Transplant，2016，21（3）：246-252．
|
| 27 |
Talaie T，DiChiacchio L，Prasad NK，et al．Ischemia-reperfusion Injury in the Transplanted Lung: A Literature Review[J]．Transplant Direct，2021，7（2）：e652．
|
| 28 |
Ali A，Wang A，Ribeiro RVP，et al．Static lung storage at 10°C maintains mitochondrial health and preserves donor organ function[J]．Sci Transl Med，2021，13（611）：eabf7601．
|
| 29 |
Steen S，Sjöberg T，Pierre L，et al．Transplantation of lungs from a non-heart-beating donor[J]．Lancet，2001，357（9259）：825-829．
|
| 30 |
Cypel M，Yeung JC，Liu M，et al．Normothermic ex vivo lung perfusion in clinical lung transplantation[J]．N Engl J Med，2011，364（15）：1431-1440．
|
| 31 |
Yeung JC，Krueger T，Yasufuku K，et al．Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study[J]．Lancet Respir Med，2017，5（2）：119-124．
|
| 32 |
Leiva-Juárez MM，Urso A，Arango Tomás E，et al．Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study[J]．J Heart Lung Transplant，2020，39（9）：954-961．
|
| 33 |
Charles EJ，Mehaffey JH，Sharma AK，et al．Lungs donated after circulatory death and prolonged warm ischemia are transplanted successfully after enhanced ex vivo lung perfusion using adenosine A2B receptor antagonism[J]．J Thorac Cardiovasc Surg，2017，154（5）：1811-1820．
|
| 34 |
Luc JG，Bozso SJ，Freed DH，et al．Successful repair of donation after circulatory death lungs with large pulmonary embolus using the lung organ care system for ex vivo thrombolysis and subsequent clinical transplantation[J]．Transplantation，2015，99（1）：e1-e2．
|
| 35 |
Machuca TN，Cypel M，Bonato R，et al．Safety and Efficacy of Ex Vivo Donor Lung Adenoviral IL-10 Gene Therapy in a Large Animal Lung Transplant Survival Model[J]．Hum Gene Ther，2017，28（9）：757-765．
|
| 36 |
Nykänen AI，Mariscal A，Duong A，et al．Engineered mesenchymal stromal cell therapy during human lung ex vivo lung perfusion is compromised by acidic lung microenvironment[J]．Mol Ther Methods Clin Dev，2021，23：184-197．
|
| 37 |
Nakajima D，Watanabe Y，Ohsumi A，et al．Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation[J]．J Heart Lung Transplant，2019，38（11）：1214-1223．
|
| 38 |
Nakajima D，Cypel M，Bonato R，et al．Ex Vivo Perfusion Treatment of Infection in Human Donor Lungs[J]．Am J Transplant，2016，16（4）：1229-1237．
|
| 39 |
Nakajima D，Liu M，Ohsumi A，et al．Lung Lavage and Surfactant Replacement During Ex Vivo Lung Perfusion for Treatment of Gastric Acid Aspiration-Induced Donor Lung Injury[J]．J Heart Lung Transplant，2017，36（5）：577-585．
|
| 40 |
Hijiya K，Chen-Yoshikawa TF，Kondo T，et al．Bronchodilator Inhalation During Ex Vivo Lung Perfusion Improves Posttransplant Graft Function After Warm Ischemia[J]．Ann Thorac Surg，2017，103（2）：447-453．
|